P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Hashimoto A, Oikawa T, Hashimoto S, Sugino H, Yoshikawa A, Otsuka Y, Handa H, Onodera Y, Nam JM, Oneyama C, Okada M, Fukuda M, Sabe H.
Hashimoto A, et al. Among authors: yoshikawa a.
J Cell Biol. 2016 Apr 11;213(1):81-95. doi: 10.1083/jcb.201510002. Epub 2016 Apr 4.
J Cell Biol. 2016.
PMID: 27044891
Free PMC article.